http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2698633-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe216aafd92230af08bea3ad94a69638 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9b07b7de18e9c3d5964c892f59770d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_944e6b0c8f36ef698e592ecad1b45acb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_934580d713dcfc8df44ebcae9fce287a |
| publicationDate | 2019-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2698633-C1 |
| titleOfInvention | Method for surgical treatment of macular retina ruptures |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to medicine, namely ophthalmosurgery. For surgical treatment of macular ruptures of retina, 3-port vitrectomy 25-27G of valve type is performed with separation and removal of posterior hyaloid membrane, colouring and removal of internal boundary membrane (IBM), replacement of balanced salt solution (BSS) with air and application of drop of blood plasma enriched with thrombocytes on the rupture area. Before painting IBM on the macular rupture a perfluororganic compound (PFOC), which, after staining, aspirated, and after complete replacement of BSS by air and application on region of rupture of droplets of blood plasma enriched with thrombocytes, one minute is waited to form fibrin film. Then, fibrin film is coated with drop PFOC, wait 5 minutes, then by passive aspiration remove a drop PFOC and replacing air with BSS.EFFECT: method enables reducing operational and postoperative complications and providing more comfortable conditions for the patient in the postoperative period without leaving a swelling agent in the eye.1 cl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2754514-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2773204-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2763477-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2803007-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2784954-C1 |
| priorityDate | 2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.